China Eases Export Rules: Following talks between U.S. President Trump and Chinese President Xi, China has suspended export limits on rare earths and vital minerals, signaling a temporary truce in the ongoing trade conflict that has affected supply chains for chips and batteries.
U.S. Tariff Adjustments: In response, the U.S. government agreed to reduce some tariffs on Chinese goods by 10% and delay new reciprocal tariffs, facilitating a smoother flow of essential materials for both countries.
Beneficiaries of Policy Shift: Companies in the semiconductor, electric vehicle, and clean energy sectors, including Intel, Tesla, and Apple, are expected to benefit from the relaxed export rules, which could lower costs and stabilize supply chains.
Short-Term Relief with Long-Term Rivalry: While the suspension of export limits provides immediate relief, it is temporary and both nations continue to view critical minerals as strategic assets in their broader trade and technology rivalry.
Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is 19.00 USD with a low forecast of 10.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is 19.00 USD with a low forecast of 10.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 7.525
Low
10.00
Averages
19.00
High
25.00
Current: 7.525
Low
10.00
Averages
19.00
High
25.00
Northland
Gus Richard
Outperform
to
Underperform
downgrade
$25 -> $16
2025-11-17
Reason
Northland
Gus Richard
Price Target
$25 -> $16
AI Analysis
2025-11-17
downgrade
Outperform
to
Underperform
Reason
Northland analyst Gus Richard lowered the firm's price target on Enovix to $16 from $25 and keeps an Outperform rating on the shares. The firm, which is adjusting estimates for a slower ramp of mobile phone revenue, calls the delay of the mobile phone ramp "disappointing," particularly after Enovix raised over $500M in Q3. The firm, which contends that it is "very likely consensus estimates for CY26 are too high," notes that its own estimates for calendar year 2026 are the "Street low."
JPMorgan
Neutral
downgrade
$12 -> $10
2025-11-12
Reason
JPMorgan
Price Target
$12 -> $10
2025-11-12
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Enovix to $10 from $12 and keeps a Neutral rating on the shares. The firm updated the company's model.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ENVX
Unlock Now
Canaccord
Buy
maintain
$22 -> $21
2025-11-06
Reason
Canaccord
Price Target
$22 -> $21
2025-11-06
maintain
Buy
Reason
Canaccord lowered the firm's price target on Enovix to $21 from $22 and keeps a Buy rating on the shares. The firm says the company's statement that it sees "additional lifecycle testing following...design revision" has added about 3 to 6 months to the ramp schedule, but while it admits to being "a little frustrated with another ramp delay," it is comforted by what it views as Enovix's strong management team, great technology, and healthy balance sheet.
Canaccord
George Gianarikas
Buy
downgrade
$22 -> $21
2025-11-06
Reason
Canaccord
George Gianarikas
Price Target
$22 -> $21
2025-11-06
downgrade
Buy
Reason
Canaccord analyst George Gianarikas lowered the firm's price target on Enovix to $21 from $22 and keeps a Buy rating on the shares. The firm noted the quarter introduced another delay in the "hockey stick" P&L they have been anticipating and tell investors to continue to be patient.
About ENVX
Enovix Corporation is a global high-performance battery company. The Company designs, develops, manufactures, and commercializes lithium-ion (Li-ion) battery cells that increase the amount of energy density and storage capacity relative to conventional battery cells. In addition to designing its batteries, it also develops the advanced manufacturing processes needed to produce its batteries in high volume. It targets a smaller group of large customers that require custom cells. Its technology roadmap is built around a structured progression of battery nodes, with each new generation, such as the EX-1M, EX-2M, EX-3M and so on. The Company, through Routejade, Inc. (Routejade), supplies batteries for wearables, medical devices, headsets, activity trackers, and industrial equipment. Routejade offers product categories, including PD series, FLPB and ASDB series, and SLPB series. The PD series consists of rechargeable coin cells commonly used in healthcare and IoT applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
